经腹超声引导取卵技术:阴道穿刺不可行时的操作演示
本文通过视频演示经腹使用阴道探头进行卵母细胞取卵的分步技术,适用于经阴道穿刺不可行的患者。两例患者分别因既往腹部手术和先天性阴道肛门闭锁伴新阴道局部晚期癌症而无法经阴道取卵。第一例获12枚卵母细胞,8枚受精,4枚囊胚冷冻;结论认为该技术安全、有效、可行。
要点
- 经腹使用阴道探头取卵是经阴道途径不可行时的可行替代方案。
- 两例复杂盆腔解剖或病理患者均成功获得卵母细胞并冷冻保存。
- 该技术便于在缺乏腹部探头穿刺架时开展。
核心结论
- 经腹使用阴道探头进行卵母细胞取出是经阴道途径不可行患者的安全、有效、可行方法。
研究设计与样本
- 视频文章,演示经腹取卵技术,纳入两例经阴道取卵不可行的患者。
主要发现
- 第一例患者38岁,获12枚卵母细胞,8枚经常规授精受精,4枚囊胚冷冻。
关键数值与推荐
- 两例均采用促性腺激素释放激素拮抗剂方案控制性卵巢刺激。
- 取卵使用7 MHz阴道探头配一次性穿刺架和17 gauge、25-cm单腔穿刺针。
- 卵泡抽吸使用脚踏激活真空泵,负压范围105-140 mmHg。
临床怎么用
- 对经阴道穿刺不可行的患者可考虑经腹使用阴道探头取卵。
- 该技术可在缺乏腹部探头穿刺架和适配器时采用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To demonstrate the step-by-step technique for performing a transabdominal oocyte retrieval with a vaginal transducer in patients where transvaginal access is not an option. DESIGN: Video article. SUBJECTS: The first patient is a 38-year-old gravida 0 woman with prior midline laparotomy for myomectomy and endometriosis resection. In vitro fertilization was recommended after unsuccessful natural conception attempts. Her baseline antimüllerian hormone was 17 pmol/L (2.38 ng/mL). The second patient is a 26-year-old gravida 0 woman with history of multiple abdominal and pelvic surgeries because of congenital vaginal and anal atresia. She presented with locally advanced cancer of the neovagina. Her baseline antimüllerian hormone was 24 pmol/L (3.36 ng/mL). The patients included gave consent for publication and posting of the video online including social media, the journal website, scientific literature websites (such as PubMed, ScienceDirect, and Scopus, etc.) and other applicable sites. EXPOSURE: Both patients underwent controlled ovarian stimulation using a gonadotropin-releasing hormone antagonist protocol. Oocyte retrievals were performed transabdominally using a 7 MHz vaginal transducer fitted with a disposable needle guide and a 17 gauge, 25-cm single lumen aspiration needle. Follicular aspiration was performed with a pedal-activated vacuum pump with suction pressures ranging between 105-140 mmHg. MAIN OUTCOME MEASURES: Oocyte yield after transabdominal oocyte retrieval. RESULTS: The first patient's in vitro fertilization cycle yielded 12 oocytes, of which 8 fertilized with conventional insemination; four blastocysts were cryopreserved. A frozen embryo transfer is planned imminently. Twenty-one oocytes were retrieved in the second patient, of which 12 mature oocytes were cryopreserved for future use. She is currently undergoing radiation therapy. CONCLUSION: Transabdominal oocyte retrieval using a vaginal transducer is a safe, effective, and feasible method of oocyte retrieval in select patients where ovaries are not accessible transvaginally. This technique may be more easily adopted where abdominal transducer needle guides and adapters are not readily accessible, offering a practical alternative for oocyte retrieval in patients with complex pelvic anatomy or pathology.
引用
- Hasan A, Zhao K, Lu B, et al. Transabdominal retrieval of oocytes when transvaginal access is not an option: mastering an egg-cellent technique. Fertil Steril. 2026. PMID: 42107484. doi:10.1016/j.fertnstert.2026.04.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。